Company Analysis

Bolt Biotherapeutics, Inc. (BOLT)

Nasdaq: BOLT · Pharmaceutical Preparations · Redwood City, CA · filing with the SEC since 2015
Grade4.8
◀ Past 6.8● Present 4.5▶ Future 3.7
1 est.

Who runs Bolt Biotherapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Quinn William P.
President, CEO and CFO. First filing Feb 2021, latest Sep 21, 2026, 7 filings in all.
Officers reporting now
4
of 9 people with a filing in the last fifteen months
Directors reporting now
5
19 people on the record since 2021
Officerssales are open-market, Nov 10, 2025 to Nov 10, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Gujrathi SheilaChief Strategy OfficerOct 2026Oct 27, 2026none
Quinn William P.President, CEO and CFOFeb 2021Sep 21, 20263 · $100,000
Yonehiro GrantChief Operating OfficerFeb 2021Sep 21, 20263 · $0.00
Nemec SarahSenior VP, Finance and PAOMay 2024Sep 21, 20263 · $0.00
Directorssales are open-market, Nov 10, 2025 to Nov 10, 2026
NameRoleFirst filingLatest filingSales, 12 months
Berner LauradirectorDec 2022Jun 11, 2026none
Dupont JakobdirectorSep 2024Jun 11, 2026none
Laporte KathleendirectorFeb 2021Jun 11, 2026none
O'Callaghan BriandirectorNov 2021Jun 11, 2026none
Onetto NicoledirectorDec 2021Jun 11, 2026none
Owners of more than 10% of a classsales are open-market, Nov 10, 2025 to Nov 10, 2026
NameRoleFirst filingLatest filingSales, 12 months
Coastlands Capital LP10% ownerNov 2026Nov 10, 2026none
Earlier names on the record23, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton BOLT · research, not advice